Angela Vigliotti v. HHS - Influenza, Multiple Sclerosis (2018)

Filed 2012-05-03Decided 2018-06-25Vaccine Influenza
compensated$100,000

Case summary [AI summaries can sometimes make mistakes]

Angela Vigliotti filed a petition on May 3, 2012, alleging that an influenza vaccine she received on September 8, 2010, caused or significantly aggravated her multiple sclerosis (MS). The respondent denied that the flu vaccine caused or significantly aggravated petitioner's MS or any other injury.

Despite these positions, both parties filed a joint stipulation on May 31, 2018, agreeing to settle the case. Special Master Thomas L.

Gowen reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court. Petitioner was awarded compensation in two parts: a lump sum of $100,000.00, payable to Angela Vigliotti, representing all damages available under 42 U.S.C. § 300aa-15(a); and a lump sum of $2,037.94, representing reimbursement of a New York Medicaid lien, payable jointly to petitioner and the New York State Department of Health, Resource Department, located at 1031 Development Court, Kingston, NY 12401.

Petitioner agreed to endorse the check for the lien amount to the New York State Department of Health. The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses.

Petitioner was represented by Mark T. Sadaka of Mark T.

Sadaka, LLC. Respondent was represented by Lynn E.

Ricciardella of the United States Department of Justice.

Theory of causation

Petitioner Angela Vigliotti alleged that an influenza vaccine administered on September 8, 2010, caused-in-fact or significantly aggravated her multiple sclerosis (MS). Respondent denied causation or aggravation. The parties reached a joint stipulation on May 31, 2018, to settle the case. Special Master Gowen adopted the stipulation as the decision of the Court. The award included a $100,000.00 lump sum for general damages and $2,037.94 for a New York Medicaid lien. The public decision does not detail the specific medical mechanism, expert testimony, or clinical evidence presented. Petitioner's counsel was Mark T. Sadaka, and respondent's counsel was Lynn E. Ricciardella. The decision date was June 25, 2018.

Source PDFs 3 total · 1 downloaded